more

Doximity (DOCS)

(Real Time Quote from BATS)

$35.06 USD

-0.54 (-1.52%)

Updated Aug 12, 2024 03:52 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.03%
2	Buy	17.70%
3	Hold	9.37%
4	Sell	5.03%
5	Strong Sell	2.48%
S&P	500	11.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth B Momentum B VGM

Industry Rank:

Bottom 41% (148 out of 250)

Industry: Medical Services

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Surgery Partners (SGRY) Reports Q2 Loss, Misses Revenue Estimates

by Zacks Equity Research Published on August 02,2022

Surgery Partners (SGRY) delivered earnings and revenue surprises of 0% and 1.48%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

AVTR or DOCS: Which Is the Better Value Stock Right Now?

by Zacks Equity Research Published on July 15,2022

AVTR vs. DOCS: Which Stock Is the Better Value Option?

by Zacks Equity Research Published on June 29,2022

AVTR vs. DOCS: Which Stock Is the Better Value Option?

Doximity (DOCS) Surges 6.6%: Is This an Indication of Further Gains?

by Zacks Equity Research Published on June 27,2022

Doximity (DOCS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Company News for May 19, 2022

by Zacks Equity Research Published on May 19,2022

Companies in The News Are: LOW,SCVL,DOCS,AUTO

Doximity (DOCS) to Report Q4 Earnings: What's in the Offing?

by Zacks Equity Research Published on May 16,2022

Doximity's (DOCS) fiscal fourth-quarter results are likely to reflect continued strength in its telehealth platform.

Doximity (DOCS) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research Published on April 28,2022

Doximity (DOCS) closed the most recent trading day at $42.54, moving -1.76% from the previous trading session.

DOCSNegative Net Change

Doximity (DOCS) Gains As Market Dips: What You Should Know

by Zacks Equity Research Published on April 11,2022

Doximity (DOCS) closed at $48.83 in the latest trading session, marking a +0.04% move from the prior day.

DOCSNegative Net Change

Will Doximity (DOCS) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research Published on April 11,2022

Doximity (DOCS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

DOCSNegative Net Change

Doximity (DOCS) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research Published on April 05,2022

Doximity (DOCS) closed at $53.23 in the latest trading session, marking a -1.43% move from the prior day.

DOCSNegative Net Change

Doximity (DOCS) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research Published on March 30,2022

In the latest trading session, Doximity (DOCS) closed at $51.81, marking a -1.45% move from the previous day.

DOCSNegative Net Change

Doximity (DOCS) Gains As Market Dips: What You Should Know

by Zacks Equity Research Published on March 23,2022

Doximity (DOCS) closed the most recent trading day at $50.47, moving +1.55% from the previous trading session.

DOCSNegative Net Change

Has Aptinyx Inc. (APTX) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research Published on March 21,2022

Here is how Aptinyx Inc. (APTX) and Doximity (DOCS) have performed compared to their sector so far this year.

Ensign Group (ENSG) Up 9.9% in 3 Months: More Room to Grow?

by Zacks Equity Research Published on March 15,2022

Ensign Group (ENSG) expects annual revenues for 2022 in the band of $2.93-$2.98 billion, whose midpoint signals a 12.4% rise from the 2021 reported figure.

Here's How Mednax (MD) Can Gain By Adopting the Pediatrix Brand

by Zacks Equity Research Published on March 03,2022

Mednax (MD) bringing some of its operations under the Pediatrix brand is expected to collectively promote its wide range of healthcare services.

medical

How Much Upside is Left in Doximity (DOCS)? Wall Street Analysts Think 32%

by Zacks Equity Research Published on March 02,2022

The mean of analysts' price targets for Doximity (DOCS) points to a 32.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

DOCSNegative Net Change

OCDX vs. DOCS: Which Stock Is the Better Value Option?

by Zacks Equity Research Published on February 25,2022

OCDX vs. DOCS: Which Stock Is the Better Value Option?

DOCSNegative Net Change

Teladoc (TDOC) Q4 Loss Narrows on Higher Visits, Memberships

by Zacks Equity Research Published on February 23,2022

Teladoc (TDOC) projects 2022 total visits in the band of 18.5-20 million, indicating an uptick from the 2021 level of 15.4 million.

Wall Street Analysts Believe Doximity (DOCS) Could Rally 36%: Here's is How to Trade

by Zacks Equity Research Published on February 14,2022

The average of price targets set by Wall Street analysts indicates a potential upside of 36.2% in Doximity (DOCS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.